Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,942 | 6,181 | 3,147 | 9,940 | 7,074 |
| Marketable Securities | 18,186 | N/A | N/A | N/A | N/A |
| Receivables | 83 | 11 | 147 | 192 | 126 |
| TOTAL | $25,261 | $6,218 | $3,294 | $10,132 | $7,199 |
| Non-Current Assets | |||||
| PPE Net | 1,135 | 483 | 143 | 216 | 67 |
| Investments And Advances | 300 | N/A | N/A | N/A | N/A |
| Intangibles | 4,850 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 300 | 0 | 0 | 0 | 0 |
| TOTAL | $6,585 | $483 | $143 | $216 | $67 |
| Total Assets | $31,846 | $6,701 | $3,438 | $10,348 | $7,266 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 97 | 194 | 1,684 | 1,446 | 1,057 |
| TOTAL | $706 | $402 | $1,772 | $1,489 | $1,436 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -2,243 | 0 | 0 | 0 | 0 |
| TOTAL | $645 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,351 | $402 | $1,772 | $1,489 | $1,436 |
| Shareholders' Equity | |||||
| Common Shares | 87,207 | 61,951 | 53,334 | 53,209 | 48,456 |
| Retained earnings | -63,750 | -56,927 | -52,848 | -45,414 | -43,463 |
| Other shareholders' equity | 4,496 | 1,276 | 1,161 | 1,064 | 837 |
| TOTAL | $27,953 | $6,299 | $1,647 | $8,859 | $5,830 |
| Total Liabilities And Equity | $29,304 | $6,701 | $3,419 | $10,348 | $7,266 |